FarmavitaR+

1. Advances in Imaging Biomarkers
(Reports/Market Report)

... in drug discovery & development & current use in clinical practice. It also outlines key collaborative initiatives in standardizing imaging technologies & informatics, improving quantification ...

2. Clinical Trials 2010
(Events/Events)

... the premier forum for senior-level clinical operations executives to work together and challenge the accepted drug development paradigm and drive change. The program is designed to help you build and execute ...

3. Ukraine in prospect of joining PIC/S
(Regulatory Affairs/Europe not-EU)

19-20 May 2010 in Geneva a meeting of the Executive Committee of the PIC / S was held. The Ukrainian delegation, headed by Alexei Soloviev, Chairman of the State Inspectorate for Quality Control of Drugs ...

4. Achieving preferential patient-access through innovative agreements with payers
(Events/Events)

... and patients. The industry faces a sustained increase in the cost of healthcare and an ever-increase in the range of expensive drugs and technologies available as potential therapies. In light of this, ...

5. Long-term pricing & reimbursement strategies to penetrate significant growth markets
(Events/Events)

... healthcare system and media‘s agenda, when compared to the very expensive cancer or orphan drugs, for example. Typically, drugs for chronic diseases are priced at very reasonable levels, yet are making ...

6. Drug Repositioning & R&D Enhancement
(Events/Events)

3rd Annual Drug Repositioning & R&D Enhancement September 16-17, 2010 Philadelphia, PA, USA This conference will showcase more than 15 industry perspectives on the most effective scientific ...

7. Evolution Summit 2010
(Events/Events)

... directly to top decision makers. Over three days, sponsors will meet and interact with senior drug development executives through a number of one-to-one business meetings and many networking activities. ...

8. eCTD
(Events/Events)

... Regulatory Operations, PIM Steering Committee Co-Chair, EFPIA • Dr Klaus Menges, Division Strategy and Planning - Unit Scientific Quality Assurance and Process Organisation, Federal Institute for Drugs ...

9. Fibromyalgia
(Regulatory Affairs/Regulatory Affairs News)

... perception surrounding the drug's formulation, its prescription constraints and abuse potential. Read more...  ...

10. Advertising of Reimbursed Drugs
(Pricing and Reimbursment/Pricing and Reimbursment)

Croatia - Agreement on Ethical Advertising of Reimbursed Drugs Due to the new Croatian Ordinance on pricing and reimbursement from this year , every MAH who wants to have its products on reimbursement ...

11. Pricing and Reimbursement Conference Review
(Pricing and Reimbursment/Pricing and Reimbursment)

...  Risk-shared agreements include responsibility of both sides (government and manufacturing) for the failure/success of drug. The largest number of these agreements exists in Australia (country known ...

12. Introduction of Braille script for pharmaceuticals in Ukraine
(Regulatory Affairs/Europe not-EU)

... 7 years preparation for new law concerning the Braille script. What does it mean for producers of drugs? All new registration and renewal procedures from 01.01.10 would include part respondent ...

13. Key Trends In Drug-diagnostic Co-development
(Reports/Market Report)

Key Trends In Drug-diagnostic Co-development: Identifying collaborative opportunities and navigating regulatory challenges This report explores the potential for applying genomic-based diagnostics to ...

14. The Top 10 Biosimilar Players
(Reports/Market Report)

... by conventional drugs. The rapid penetration of novel biologics and the gradual expiry of their patents will create significant market opportunities for biosimilars developers through to 2016. In the ...

15. New Approaches to Pharma R&D
(Reports/Market Report)

... under greater pressure to fill their pipelines with innovative drugs. However, despite the costs and risks involved in drug development, the pharma industry is finding new ways to streamline the R&D process ...

16. Clinical Trial in India
(Clinical Trilas/Asia)

... article is available for download at Downloads section of FarmavitaR.com Drug trials, commonly known as clinical trials, are scientific tests made on human volunteers. Such trials are carried out in ...

17. Standardization of Herbal Drugs
(Professional Articles/Life Science Article)

Challenges in standardization in Traditional Medicine / Herbal Drugs The use of herbs and herbal extracts to treat diseases has stood the test of time. Herbal products/traditional medicine are composed ...

18. Act on Medical Products and Medical Devices
(Regulatory Affairs/Europe not-EU)

... at Downloads section of Farmavitar.Net. (in Bosnian!) This law also applies to the medical products that contain drugs and psychotropic substances, as well as the raw materials used in their production. ...

19. Registration of the drugs in the Republic of Albania
(Regulatory Affairs/Europe not-EU)

ON THE REGISTRATION OF THE DRUGS IN THE REPUBLIC OF ALBANIA FarmavitaR+ brings you a short description of drugs registration procedure in the Republic of Albania. The whole 12 pages article is available ...

20. Croatia - Pricing and Reimbursement News
(Pricing and Reimbursment/Pricing and Reimbursment)

Enforcement of new pricing and reimbursement ordinance in Croatia Croatian Institute for Health Insurance (HZZO) has informed all marketing authorization holders that 22nd August 2009 is deadline for ...